Next Article in Journal
Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19
Previous Article in Journal
Improved Performance of the QuantiFERON-SARS-CoV-2 Assay with the Extended Set
 
 
Article

Article Versions Notes

Viruses 2023, 15(5), 1180; https://doi.org/10.3390/v15051180
Action Date Notes Link
article xml file uploaded 17 May 2023 05:54 CEST Original file -
article xml uploaded. 17 May 2023 05:54 CEST Update https://www.mdpi.com/1999-4915/15/5/1180/xml
article pdf uploaded. 17 May 2023 05:54 CEST Version of Record https://www.mdpi.com/1999-4915/15/5/1180/pdf
article supplementary file uploaded. 17 May 2023 05:54 CEST - https://www.mdpi.com/1999-4915/15/5/1180#supplementary
article html file updated 17 May 2023 05:55 CEST Original file https://www.mdpi.com/1999-4915/15/5/1180/html
Back to TopTop